⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLSA News
Tiziana Life Sciences Ltd. Common Shares
Telia to Deploy Seamless OS Following Acquisition of Telness Operator
businesswire.com
TLSA
Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging
globenewswire.com
TLSA
Draft decisions of the Annual General Meeting of Shareholders to be held on 24 April 2026
globenewswire.com
TLSA
TCOM
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA
globenewswire.com
TLSA
Telia Lietuva results for 12 months of 2025
globenewswire.com
TLSA
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
globenewswire.com
TLSA
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million
globenewswire.com
TLSA
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco
globenewswire.com
TLSA
Alloy Therapeutics Appoints Christian Cobaugh, Ph.D., as CEO of Alloy Genetic Medicines
businesswire.com
ARCT
CRSP
MRNA
TLSA
Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA
globenewswire.com
TLSA